TARGETING INDIVIDUALS AT HIGH-RISK FOR ISCHEMIC-HEART-DISEASE - WHAT COULD WE BENEFIT FROM MEASURING FASTING INSULIN, APOLIPOPROTEIN-B AND LDL PARTICLE-SIZE
B. Lamarche et al., TARGETING INDIVIDUALS AT HIGH-RISK FOR ISCHEMIC-HEART-DISEASE - WHAT COULD WE BENEFIT FROM MEASURING FASTING INSULIN, APOLIPOPROTEIN-B AND LDL PARTICLE-SIZE, Diabetes, 46, 1997, pp. 173-173